Tonix Pharmaceuticals
About:
Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.
Website: http://www.tonixpharma.com
Twitter/X: TONIXPharma
Top Investors: Deerfield, Technology Partners, Broadfin Capital, Sabby Management
Description:
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of the central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions.
$317M
$10M to $50M
New York, New York, United States
2007-11-16
jobs(AT)tonixpharma.com
Seth Lederman
11-50
2024-06-12
Public
© 2025 bioDAO.ai